Regulation and trafficking of the HLA-E molecules during monocytemacrophage differentiation

Journal of Leukocyte Biology

Volumn 99, Issue 1, 2016, Pages 121-130

  Camilli, Giorgio ^a   Cassotta, Antonino ^a   Battella, Simone ^a   Palmieri, Gabriella ^a   Santoni, Angela ^a   Paladini, Fabiana ^a   Fiorillo, Maria Teresa ^a   Sorrentino, Rosa ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Human leukocyte antigen E; Monocytic; NK cells

Indexed keywords

HLA ANTIGEN CLASS 1; HLA E ANTIGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MICROTUBULE ASSOCIATED PROTEIN; MICROTUBULE ASSOCIATED PROTEIN LIGHT CHAIN 3; UNCLASSIFIED DRUG; HLA-E ANTIGEN; METALLOPROTEINASE;

ARTICLE; AUTOPHAGY; CELL DIFFERENTIATION; CELL MEMBRANE; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYSIS; LYSOSOME; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; U937 CELL LINE; UPREGULATION; CELL CULTURE; CYTOLOGY; CYTOTOXICITY; IMMUNOLOGY; IMMUNOMODULATION; INTRACELLULAR SPACE; METABOLISM; PHAGOSOME; PROTEIN TRANSPORT; TUMOR CELL LINE;

CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MEMBRANE; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOMODULATION; INTRACELLULAR SPACE; KILLER CELLS, NATURAL; LYSOSOMES; MACROPHAGES; METALLOPROTEASES; MONOCYTES; PHAGOSOMES; PROTEIN TRANSPORT; UP-REGULATION;

EID: 84953406079     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1A0415-172R     Document Type: Article

References (46)

1. Koller, B. H., Geraghty, D. E., Shimizu, Y., DeMars, R., Orr, H. T. (1988) HLA-E. A novel HLA class I gene expressed in resting T lymphocytes. J. Immunol. 141, 897–904.
2. Wei, X. H., Orr, H. T. (1990) Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissue. Hum. Immunol. 29, 131-142.
3. Grimsley, C., Kawasaki, A., Gassner, C., Sageshima, N., Nose, Y., Hatake, K., Geraghty, D. E., Ishitani, A. (2002) Definitive high resolution typing of HLA-E allelic polymorphisms: identifying potential errors in existing allele data. Tissue Antigens 60, 206-212.
4. Hodgkinson, A. D., Millward, B. A., Demaine, A. G. (2000) The HLA-E locus is associated with age at onset and susceptibility to type 1 diabetes mellitus. Hum. Immunol. 61, 290-295.
5. Lin, Y. J., Wan, L., Wu, J. Y., Sheu, J. J., Lin, C. W., Lan, Y. C., Lai, C. H., Hung, C. H., Tsai, Y., Tsai, C. H., Lin, T. H., Lin, J. G., Hsueh, K. C., Huang, Y. M., Chang, J. S., Tsai, F. J. (2009) HLA-E gene polymorphism associated with susceptibility to Kawasaki disease and formation of coronary artery aneurysms. Arthritis Rheum. 60, 604-610.
6. Paladini, F., Belfiore, F., Cocco, E., Carcassi, C., Cauli, A., Vacca, A., Fiorillo, M. T., Mathieu, A., Cascino, I., Sorrentino, R. (2009) HLA-E gene polymorphism associates with ankylosing spondylitis in Sardinia. Arthritis Res. Ther. 11, R171.
7. Park, K. S., Park, J. S., Nam, J. H., Bang, D., Sohn, S., Lee, E. S. (2007) HLA-E*0101 and HLA-G*010101 reduce the risk of Behcet’s disease. Tissue Antigens 69, 139-144.
8. Tamouza, R., Busson, M., Fortier, C., Diagne, I., Diallo, D., Sloma, I., Contouris, H., Krishnamoorthy, R., Labie, D., Girot, R., Charron, D. (2007) HLA-E*0101 allele in homozygous state favors severe bacterial infections in sickle cell anemia. Hum. Immunol. 68, 849-853.
9. Braud, V., Jones, E. Y., McMichael, A. (1997) The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur. J. Immunol. 27, 1164-1169.
10. Braud, V. M., Allan, D. S., Wilson, D., McMichael, A. J. (1998) TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr. Biol. 8, 1-10.
11. Lee, N., Goodlett, D. R., Ishitani, A., Marquardt, H., Geraghty, D. E. (1998) HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol. 160, 4951-4960.
12. Braud, V. M., Allan, D. S., O’Callaghan, C. A., Söderström, K., D’Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., Lanier, L. L., McMichael, A. J. (1998) HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391, 795-799.
13. Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., López-Botet, M., Geraghty, D. E. (1998) HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 95, 5199-5204.
14. Borrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E., Brooks, A. G. (1998) Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 187, 813-818.
15. Michaëlsson, J., Teixeira de Matos, C., Achour, A., Lanier, L. L., Kärre, K., Söderström, K. (2002) A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J. Exp. Med. 196, 1403-1414.
16. Wooden, S. L., Kalb, S. R., Cotter, R. J., Soloski, M. J. (2005) Cutting edge: HLA-E binds a peptide derived from the ATP-binding cassette transporter multidrug resistance-associated protein 7 and inhibits NK cell-mediated lysis. J. Immunol. 175, 1383-1387.
17. Heinzel, A. S., Grotzke, J. E., Lines, R. A., Lewinsohn, D. A., McNabb, A. L., Streblow, D. N., Braud, V. M., Grieser, H. J., Belisle, J. T., Lewinsohn, D. M. (2002) HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells. J. Exp. Med. 196, 1473-1481.
18. Jørgensen, P. B., Livbjerg, A. H., Hansen, H. J., Petersen, T., Höllsberg, P. (2012) Epstein-Barr virus peptide presented by HLA-E is predominantly recognized by CD8(bright) cells in multiple sclerosis patients. PLoS One 7, e46120.
19. Nattermann, J., Nischalke, H. D., Hofmeister, V., Ahlenstiel, G., Zimmermann, H., Leifeld, L., Weiss, E. H., Sauerbruch, T., Spengler, U. (2005) The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells. Am. J. Pathol. 166, 443-453.
20. Nattermann, J., Nischalke, H. D., Hofmeister, V., Kupfer, B., Ahlenstiel, G., Feldmann, G., Rockstroh, J., Weiss, E. H., Sauerbruch, T., Spengler, U. (2005) HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells. Antivir. Ther. (Lond.) 10, 95-107.
21. Tomasec, P., Braud, V. M., Rickards, C., Powell, M. B., McSharry, B. P., Gadola, S., Cerundolo, V., Borysiewicz, L. K., McMichael, A. J., Wilkinson, G. W. (2000) Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287, 1031.
22. Li, J., Goldstein, I., Glickman-Nir, E., Jiang, H., Chess, L. (2001) Induction of TCR Vbeta-specific CD8+ CTLs by TCR Vbeta-derived peptides bound to HLA-E. J. Immunol. 167, 3800-3808.
23. Pietra, G., Romagnani, C., Mazzarino, P., Falco, M., Millo, E., Moretta, A., Moretta, L., Mingari, M. C. (2003) HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. Proc. Natl. Acad. Sci. USA 100, 10896-10901.
24. Salerno-Gonçalves, R., Fernandez-Viña, M., Lewinsohn, D. M., Sztein, M. B. (2004) Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J. Immunol. 173, 5852-5862.
25. Schulte, D., Vogel, M., Langhans, B., Krämer, B., Körner, C., Nischalke, H. D., Steinberg, V., Michalk, M., Berg, T., Rockstroh, J. K., Sauerbruch, T., Spengler, U., Nattermann, J. (2009) The HLA-E(R)/HLA-E(R) genotype affects the natural course of hepatitis C virus (HCV) infection and is associated with HLA-E-restricted recognition of an HCV-derived peptide by interferon-gamma-secreting human CD8(+) T cells. J. Infect. Dis. 200, 1397-1401.
26. Jiang, H., Canfield, S. M., Gallagher, M. P., Jiang, H. H., Jiang, Y., Zheng, Z., Chess, L. (2010) HLA-E-restricted regulatory CD8(+) T cells are involved in development and control of human autoimmune type 1 diabetes. J. Clin. Invest. 120, 3641-3650.
27. Joosten, S. A., van Meijgaarden, K. E., van Weeren, P. C., Kazi, F., Geluk, A., Savage, N. D., Drijfhout, J. W., Flower, D. R., Hanekom, W. A., Klein, M. R., Ottenhoff, T. H. (2010) Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity. PLoS Pathog. 6, e1000782.
28. Sarantopoulos, S., Lu, L., Cantor, H. (2004) Qa-1 restriction of CD8+ suppressor T cells. J. Clin. Invest. 114, 1218-1221.
29. Furukawa, H., Yabe, T., Akaza, T., Tadokoro, K., Tohma, S., Inoue, T., Tokunaga, K., Yamamoto, K., Geraghty, D. E., Juji, T. (1999) Cell surface expression of HLA-E molecules on PBMC from a TAP1-deficient patient. Tissue Antigens 53, 292-295.
30. Lorente, E., Infantes, S., Abia, D., Barnea, E., Beer, I., García, R., Lasala, F., Jiménez, M., Mir, C., Morreale, A., Admon, A., López, D. (2012) A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule. J. Biol. Chem. 287, 34895-34903.
31. Lo Monaco, E., Sibilio, L., Melucci, E., Tremante, E., Suchànek, M., Horejsi, V., Martayan, A., Giacomini, P. (2008) HLA-E: strong association with beta2-microglobulin and surface expression in the absence of HLA class I signal sequence-derived peptides. J. Immunol. 181, 5442-5450.
32. Pisegna, S., Pirozzi, G., Piccoli, M., Frati, L., Santoni, A., Palmieri, G. (2004) p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells. Blood 104, 4157-4164.
33. Zhang, Y., Morgan, M. J., Chen, K., Choksi, S., Liu, Z. G. (2012) Induction of autophagy is essential for monocyte-macrophage differentiation. Blood 119, 2895-2905.
34. Pietra, G., Romagnani, C., Manzini, C., Moretta, L., Mingari, M. C. (2010) The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors. J. Biomed. Biotechnol. 2010, 907092.
35. Morandi, F., Airoldi, I., Pistoia, V. (2014) IL-27 driven upregulation of surface HLA-E expression on monocytes inhibits IFN-g release by autologous NK cells. J. Immunol. Res. 2014, 938561.
36. Vogel, K., Thomann, S., Vogel, B., Schuster, P., Schmidt, B. (2014) Both plasmacytoid dendritic cells and monocytes stimulate natural killer cells early during human herpes simplex virus type 1 infections. Immunology 143, 588-600.
37. Coupel, S., Moreau, A., Hamidou, M., Horejsi, V., Soulillou, J. P., Charreau, B. (2007) Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood 109, 2806-2814.
38. Shwetank, Date O. S., Carbone, E., Manjunath, R. (2014) Inhibition of ERK and proliferation in NK cell lines by soluble HLA-E released from Japanese encephalitis virus infected cells. Immunol. Lett. 162 (1 Pt A), 94-100.
39. Crotzer, V. L., Blum, J. S. (2009) Autophagy and its role in MHCmediated antigen presentation. J. Immunol. 182, 3335-3341.
40. Lampen, M. H., Hassan, C., Sluijter, M., Geluk, A., Dijkman, K., Tjon, J. M., de Ru, A. H., van der Burg, S. H., van Veelen, P. A., van Hall, T. (2013) Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2. Mol. Immunol. 53, 126-131.
41. Grotzke, J. E., Harriff, M. J., Siler, A. C., Nolt, D., Delepine, J., Lewinsohn, D. A., Lewinsohn, D. M. (2009) The Mycobacterium tuberculosis phagosome is a HLA-I processing competent organelle. PLoS Pathog. 5, e1000374.
42. Hayashi-Nishino, M., Fujita, N., Noda, T., Yamaguchi, A., Yoshimori, T., Yamamoto, A. (2009) A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formation. Nat. Cell Biol. 11, 1433-1437.
43. Ylä-Anttila, P., Vihinen, H., Jokitalo, E., Eskelinen, E. L. (2009) 3D tomography reveals connections between the phagophore and endoplasmic reticulum. Autophagy 5, 1180-1185.
44. Ulbrecht, M., Kellermann, J., Johnson, J. P., Weiss, E. H. (1992) Impaired intracellular transport and cell surface expression of nonpolymorphic HLA-E: evidence for inefficient peptide binding. J. Exp. Med. 176, 1083-1090.
45. Levine, B., Mizushima, N., Virgin, H. W. (2011) Autophagy in immunity and inflammation. Nature 469, 323-335.
46. Odyniec, A. N., Barral, D. C., Garg, S., Tatituri, R. V., Besra, G. S., Brenner, M. B. (2010) Regulation of CD1 antigen-presenting complex stability. J. Biol. Chem. 285, 11937-11947.